Pakistani Pharmaceuticals & Biotech Strong Balance Sheet Stocks

GlaxoSmithKline Pakistan

Market Cap: PK₨143.2b

Operates as a biopharma company in Pakistan.

Macter International

Market Cap: PK₨18.0b

A contract manufacturer, manufactures and markets pharmaceutical products and formulations for healthcare companies in Pakistan.

Hoechst Pakistan

Market Cap: PK₨38.6b

Engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally.

Highnoon Laboratories

Market Cap: PK₨60.4b

Manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.

Abbott Laboratories (Pakistan)

Market Cap: PK₨120.9b

Manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland.

Ferozsons Laboratories

Market Cap: PK₨17.5b

Engages in the importing, manufacturing, and sale of pharmaceutical products and medical devices in Pakistan, Afghanistan, Sri Lanka, the Philippines, Kenya, Myanmar, Kyrgyzstan, Mongolia, Cambodia, and internationally.

Liven Pharmaceuticals

Market Cap: PK₨6.2b

Manufactures and markets pharmaceutical products in Pakistan.

Citi Pharma

Market Cap: PK₨22.5b

Engages in the manufacture and sale of pharmaceutical, medical chemical, and botanical products in Pakistan.

Searle

Market Cap: PK₨60.2b

Manufactures and sells pharmaceutical and other consumer products in Pakistan, Sri Lanka, Myanmar, Cambodia, Vietnam, Iraq, Oman, Afghanistan, Tajikistan, Laos, Kenya, and internationally.

Otsuka Pakistan

Market Cap: PK₨3.9b

Manufactures, markets, and distributes intravenous infusions in Pakistan and Afghanistan.

BF Biosciences

Market Cap: PK₨14.3b

A diversified biotech pharmaceutical company, manufactures, imports, and sells pharmaceutical products.